Show simple item record

dc.contributor.authorFormiga, Francesc
dc.contributor.authorFerrer, Assumpta
dc.contributor.authorPadros, Gloria
dc.contributor.authorMontero, Abelardo
dc.contributor.authorGimenez-Argente, Carme
dc.contributor.authorCorbella Virós, Xavier
dc.date.accessioned2020-02-02T16:00:31Z
dc.date.available2020-02-02T16:00:31Z
dc.date.issued2016-04-18
dc.identifier.citationFormiga, Francesc; Ferrer, Assumpta; Padros, Gloria [et al.]. Evidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX study. Clinical Interventions in Aging, 2016, vol. 11, p. 437-444. Disponible en: <https://www.dovepress.com/evidence-of-functional-declining-and-global-comorbidity-measured-at-ba-peer-reviewed-article-CIA>. Fecha de acceso: 2 feb. 2020. DOI: 10.2147/CIA.S101447ca
dc.identifier.issn1178-1998ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/1445
dc.description.abstractObjective: To investigate the predictive value of functional impairment, chronic conditions, and laboratory biomarkers of aging for predicting 5-year mortality in the elderly aged 85 years. Methods: Predictive value for mortality of different geriatric assessments carried out during the OCTABAIX study was evaluated after 5 years of follow-up in 328 subjects aged 85 years. Measurements included assessment of functional status comorbidity, along with laboratory tests on vitamin D, cholesterol, CD4/CD8 ratio, hemoglobin, and serum thyrotropin. Results: Overall, the mortality rate after 5 years of follow-up was 42.07%. Bivariate analysis showed that patients who survived were predominantly female (P=0.02), and they showed a significantly better baseline functional status for both basic (P<0.001) and instrumental (P<0.001) activities of daily living (Barthel and Lawton index), better cognitive performance (Spanish version of the Mini-Mental State Examination) (P<0.001), lower comorbidity conditions (Charlson) (P<0.001), lower nutritional risk (Mini Nutritional Assessment) (P<0.001), lower risk of falls (Tinetti gait scale) (P<0.001), less percentage of heart failure (P=0.03) and chronic obstructive pulmonary disease (P=0.03), and took less chronic prescription drugs (P=0.002) than nonsurvivors. Multivariate Cox regression analysis identified a decreased score in the Lawton index (hazard ratio 0.86, 95% confidence interval: 0.78–0.91) and higher comorbidity conditions (hazard ratio 1.20, 95% confidence interval: 1.08–1.33) as independent predictors of mortality at 5 years in the studied population. Conclusion: The ability to perform instrumental activities of daily living and the global comorbidity assessed at baseline were the predictors of death, identified in our 85-year-old community-dwelling subjects after 5 years of follow-up.ca
dc.format.extent8ca
dc.language.isoengca
dc.publisherDove Pressca
dc.relation.ispartofClinical Interventions in Agingca
dc.relation.ispartofseries11;
dc.rightsThis work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.ca
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/
dc.subject.otherEnvellimentca
dc.subject.otherMortalitat
dc.subject.otherComorbiditat
dc.subject.otherEnvejecimiento
dc.subject.otherMortalidad
dc.subject.otherComorbilidad
dc.subject.otherAging
dc.subject.otherMortality
dc.subject.otherComorbidity
dc.titleEvidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX studyca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca
dc.embargo.termscapca
dc.subject.udc61 - Medicina
dc.identifier.doihttps://dx.doi.org/10.2147/CIA.S101447ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/3.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint